| Abstract | Epoetin alfa therapy has dramatically improved therapeutic responses and outcomes for anemic patients with end-stage renal disease. This article examines clinical evidence supporting the correlation between patient outcomes and a higher hematocrit and addresses some of the barriers that may hinder optimal patient outcomes. |
| Authors | W R Hendrix |
| Journal | ANNA journal / American Nephrology Nurses' Association
(ANNA J)
Vol. 23
Issue 1
Pg. 46-9
(Feb 1996)
ISSN: 8750-0779 UNITED STATES |
| PMID | 8702361
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
| Chemical References |
|
| Topics |
- Activities of Daily Living
- Anemia
(blood, etiology, therapy)
- Erythropoietin
(therapeutic use)
- Female
- Hematocrit
- Humans
- Kidney Failure, Chronic
(complications)
- Middle Aged
- Quality of Life
|
